Although many questions are still left unanswered, and reasons officials believe that they should continue on with the development of the vaccine as stated by David Fedson, a vaccines expert and former professor of medicine at the University of Virginia. "It's a foregone conclusion, if we don't invest in an H1N1 (swine flu) vaccine, then possibly we could have a reappearance of this virus in a mild, moderate, or catastrophic form and we would have absolutely nothing."
T
o connect with more professionals in the Vaccines field, join our Vaccines Development Forum Group on LinkedIn or join us in Boston September 23-25 for the Vaccines Development Forum.
|
Share this article with your social network, just click below to share now!
|
|
|








No comments :
Post a Comment